Young Investigator Award
This grant funds early-stage clinical research to develop new treatments and management strategies for neurofibromatosis (NF), with a focus on innovation and improving patient outcomes.
Funder: Children’s Tumor Foundation
Due Dates (Anticipated): December 2026: Letter of Intent deadline (projected)
Funding Amounts: Up to $200,000 total over two years (inclusive of up to 10% indirect costs)
Summary: Supports early-stage clinical research to advance treatments, interventions, and management for patients with neurofibromatosis (NF).
Description
The Clinical Research Award from the Children’s Tumor Foundation (CTF) is designed to advance the development of effective clinical treatments, interventions, and management strategies for individuals living with neurofibromatosis (NF), including NF1 and all forms of schwannomatosis. The program provides two-year funding to support bold, early-stage clinical studies that have the potential to improve patient outcomes and generate data for future larger-scale research. Priority is given to proposals that introduce novel approaches, address gaps in NF care, or enable new directions for disease management.
